 Roxadustat is the first orally administered hypoxia-inducible factor HIF prolyl hydroxylase PH inhibitor available for adult patients with anemia associated with chronic kidney disease in Europe Roxadustat is the first orally administered hypoxia-inducible factor HIF prolyl hydroxylase PH inhibitor available for adult patients with anemia associated with chronic kidney disease in Europe 